Many patients benefit from the use of intravenous (IV) catheters for hemodynamic monitoring, blood sampling, or the administration of fluid, nutrition, and medication. Unfortunately, some patients develop catheterrelated infection, which increases the duration and complexity of hospitalization. The highest risk group consists of patients with central venous catheters (CVCs) in the intensive care unit (ICU), where infection may entail treatment costs of approximately $71,000 1 and an associated mortality rate of 25%. 2 Clinicians use many strategies to minimize the risk of infection, including routinely changing IV administration sets more frequently than replacing the catheter itself.
The practice of routinely changing IV administration sets is not evidence based. Prior to the 1970s, administration sets were used until they malfunctioned or were not required. 3 After the epidemic of catheter-related bacteremia that occurred during the 1970s, a 24-hour replacement of administration sets and fluids was advocated 4 and almost universally implemented despite the unrelated cause of the problem (manufacturer-contaminated fluid). 5, 6 During the past three decades, researchers have slowly challenged the premise that daily set changes are required. Several studies have shown that prolonged use of up to 72 hours does not increase the risk of infection. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Set changes at 96 hours have been found to be equivalent to changes at 48 hours 17, 18 ; changes "between day 4 and day 7" have been found to be equivalent to changes at day 3 19 ; and changes at 24, 48, 72, 96 , and 120 hours have been found to be indistinguishable from each other. 20 Surprisingly, all studies have been based on the assumption that routine administration set changes prevent infection; the focus had previously been to find an "ideal" interval for replacing sets rather than questioning the efficacy of the practice per se.
The guidelines of the Centers for Disease Control and Prevention (CDC) advise changing administration sets for standard infusions and for non-lipid parenteral infusions "no more frequently than every 72 hours." 21 The exact nature of the current practice is unknown but probably varies. In a small survey of hospitals in Australia, the United States, and Canada, the most frequently reported duration of use was 72 hours (C. Rickard, PhD candidate, unpublished data, June 15, 2000) . This seems to suggest a misinterpretation of the CDC guidelines to replace sets at 72 hours rather than no more frequently than every 72 hours.
Lipid, blood product, and propofol administration sets are slightly more complicated than those used for standard solutions. The CDC advocates changes every 24 hours for blood product and lipid sets, but every 12 hours for propofol sets.
The current study examined the effect of routinely changing administration sets (including total parenteral nutrition and lipid sets) compared with leaving them intact for the duration of catheterization on catheter colonization and infection.
METHODS

Study Setting
This study was conducted in an 18-bed general ICU in a 700-bed, tertiary-care referral hospital. The physicians in the ICU have sole admitting, discharge, and prescribing rights. Nursing staff are registered nurses (RNs), many with ICU qualifications. More than 1,200 patients are admitted annually for an average length of stay of 4 days.
Study Sample
A minimum sample size of 392 was calculated prior to the study to detect a 50% colonization difference with 80% power from a baseline audited incidence of 20% at a P value of .05. ARROWgard Blue 3-or 4-lumen CVCs coated with chlorhexidine gluconate and silver sulfadiazine (Arrow International, Inc., Reading, PA) were used. For 12 months, all CVCs inserted in the ICU and in situ on day 4 (day of insertion being day 1) were enrolled. A computerized random-number generator randomized each CVC to either receive a routine set change or have the original administration set left intact for the duration of catheterization. Individual patients could have multiple catheters in the study (the unit of measurement was the catheter).
Catheter Care
ICU medical staff inserted CVCs using an aseptic technique at a new skin site (without a guidewire), with new fluids and administration sets connected. Catheters were sutured and non-tunneled. Set changes were performed on catheter-day 4 at approximately 72 hours (± 12 hours) after insertion for the group receiving a set change. RNs in the ICU prepared administration sets and performed set changes using an aseptic technique. Disconnection sites were decontaminated with chlorhexidine.
The administration set included all connections between the CVC and the fluid container (ie, tubing, burettes, extension tubing, and pressure transducers). Fluid containers (ie, bags, bottles, and syringes) were replaced at the administration set change and every 24 hours. Blood product administration sets were discarded after transfusion. However, administration sets used for parenteral nutrition, lipids, and propofol infusions were included in the study. Administration set composition was not static. If a new infusion was required or an infusion was no longer needed, the system was accessed using a non-touch technique.
Excluding administration set changes, all other CVC care was equal between the groups. CVCs were accessed only by the RNs and medical staff in the ICU and were not used to aspirate blood. Dressings (Opsite IV3000, Smith and Nephew, Hull, United Kingdom) were changed on day 4 and if they were soiled, were loose, or had blood beneath them. Medical staff ordered CVC removal routinely on day 7 or earlier if the patient died, did not require the CVC, or was suspected to have CVC infection. Medical staff were blinded to the study group so that their decision to order catheter removal or blood or other cultures was not biased.
Catheter Culture
CVCs were removed by RNs in the ICU using a standardized aseptic technique following site decontamination with chlorhexidine. The distal portion of the CVC tip was cultured using a semiquantitative technique. 22 Laboratory staff were blinded to the study group.
Data Collection
Senior nursing staff monitored protocol adherence and collected data on microbiology results, systemic inflammatory response syndrome, 23 patient demographics, and other potential risk factors for CVC infection. A blinded intensivist reviewed microbiological results (ie, cultures of catheter tip, blood, and other sites) and cases of systemic inflammatory response syndrome using strict definitions 24 to diagnose the presence or absence of catheter-related bacteremia.
Definitions
Catheter colonization was defined as growth of 15 colony-forming units/mm 3 or more. Catheter-related bacteremia was diagnosed as definite, probable (types 1 and 2 combined), possible, or absent using previously described definitions (Table 1) . 24 These definitions were developed to address the difficulties associated with the application of the CDC surveillance definition of catheterrelated bloodstream infection (BSI) in ICU patients with multiple concurrent disease processes, colonized sites, or both, and unavailable or incomplete microbiological data. The "definite" and "possible" categories used in this study combine to equate with the CDC definition of catheterrelated BSI.
Ethical Considerations
The study was approved by the Hospital and the University Human Research Ethics Committees. Individual consent was waived considering the legal incompetence of the patients. State legislation precluded relatives from considering consent; however, relatives were notified of enrollment, were provided information about the study, and could ask questions or request their relative's withdrawal.
Statistical Analysis
Given the varied duration of catheterization, the primary analysis of colonization between the groups was tested using the Kaplan-Meier survival curve with log-rank test. The distribution between groups of variables considered risk factors for catheter colonization was tested to assess for bias. Proportions were tested using chi-square. Differences in the mean scores on continuous variables were tested with the Student's t test. Logistic regression modeling was performed to analyze the influence of potentially confounding variables. Analysis was performed using SPSS software (version 10.0; SPSS, Inc., Chicago, IL).
RESULTS
Sample
Two hundred fifty-one patients with 404 CVCs were included in the study. Of these, 157 patients each contributed 1 CVC; the others had multiple catheters. There were 203 CVCs randomized to the group receiving a set change and 201 to the group not receiving a change. Randomization was successful in distributing most demographic variables and risk factors for infection equally between the two groups ( Table 2 ). The only significant differences between the groups were a mean 6 years in age (P = .006) and an average of 6 intravenous injections (P = .03). It is unlikely that these differences were clinically significant. There were 24,918 hours of catheter life in the group receiving a set change and 25,384 hours in the group not receiving a change.
Colonization
Twenty-nine (7.1%) of the CVCs were not cultured due to autopsy or lost or contaminated specimens. These were equally distributed between the groups (receiving a set change, n = 14; not receiving a change, n = 15). Of the 375 catheters cultured, 10 in the group receiving a set (Fig. 1) . The 29 colonized CVCs belonged to 23 patients. Four patients had multiple colonized catheters (2 patients with 2 catheters and 2 patients with 3 catheters). Of these, 3 patients had other noncolonized CVCs in the study. Of the 19 patients with a single colonized catheter, 13 had at least 1 other noncolonized CVC. A first-catheter-per-patient analysis (n = 251) was performed and no difference in colonization was found between the groups (receiving a set change, 2 colonized; not receiving a change, 8 colonized; Kaplan-Meier with log-rank test = 2.63; df = 1; P = .1047).
Colonization varied significantly among subclavian (5.0%), jugular (9.4%), and femoral (20.8%) sites (P = .001). There were also significant differences in colonization among patients with neurological (0%), surgical-trauma (5%), medical (7%), and burns (29%) diagnoses (P < .001).
Catheter-Related Bacteremia
Among the 404 patients, there were 3 cases (1 definite; 1 probable, type 1; and 1 possible) of catheter-related bacteremia in the group receiving a set change and 3 (1 probable, type 1; 1 probable, type 2; and 1 possible) in the group not receiving a change. Organisms were from the Acinetobacter, Staphylococcus, Pseudomonas, Enterobacter, and Klebsiella species. The difference in survival from rates of catheter-related bacteremia between the groups was not statistically significant (Kaplan-Meier with log-rank test, P = .862) (Fig. 2) .
Logistic Regression Model
Bivariate analysis found significant associations between catheter colonization and the following variables: age, burns diagnosis, ICU-days on catheter insertion, hospital-days on catheter insertion, Acute Physiology and Chronic Health Evaluation (APACHE) II score on the day of insertion, blood transfusion, hypoalbuminemia, suspected catheter-related bacteremia, catheter site, and subsequent catheters in patients with multiple catheters. These variables were subjected to forward stepwise logistic regression. Only two risk factors entered the multivariate model: burns diagnosis (OR, 6.845; CI 95 , 2.96 to 15.83; P < .001) and increased ICU-days on catheter insertion (OR, 1.080; CI 95 , 1.035 to 1.127; P < .001).
DISCUSSION
This study found no statistically significant difference in the rates of colonization or catheter-related bacteremia between catheters with administration sets that were routinely replaced on day 4 and catheters with administration sets that were not replaced at all. The study involved a high-risk population-short-term, antiseptic-coated CVCs from ICU patients, including those with severe burns, immunosuppression, parenteral nutrition, and lipid therapy. Survival modeling found no difference in colonization between the groups when accounting for the various durations of the implicated catheters.
The study included catheters in situ for 52 to 196 hours (mean, 124.5 hours), with a significant proportion (25%) removed on or after catheter-day 7. There were 12 catheters and administration sets that were used longer than 1 week (168 hours), with 3 of 9 colonized in the group not receiving a change and 0 of 3 in the group receiving a set change (no catheter-related bacteremia in either group). The three longest dwelling CVCs in the study were all in the group not receiving a change and were not colonized. Due to the small number of catheters studied for longer than 1 week, no conclusion can be drawn about the effect of routine replacement of the administration set after this point. Until a multicenter, ran- August 2004 domized, controlled trial confirms the study results or assesses use beyond 1 week, it would be prudent to limit administration set use to 7 days rather than an unlimited time frame. The finding that routine administration set changes had no effect is congruent with the pathogenesis of colonization in short-term catheters, whereby the skin site is the dominant route of colonization. 21 Skin-site colonization may occur as early as at catheter insertion (ie, before the administration sets are even connected) 25 and would be unlikely to be influenced by changes of the distant administration set. However, administration set replacement could theoretically influence infective routes involving the catheter hub or IV fluid. We did not see an effect of set replacement on semiquantitative catheter colonization; however, it is possible that had a different culture method favoring internal luminal culture been used, a different result may have been found. Traditionally, it has been assumed that replacement of sets would decrease circuit contamination. However, it seems equally, if not more, likely that the potential for contamination could be increased due to the additional manual handling and circuit interruption, thus providing an opportunity for microorganism entry. 26 Administration set configurations are not static throughout the catheterization, but are manipulated frequently (to add, remove, or reconfigure infusions, to replace fluid containers, or to give medications). These manipulations should involve hand hygiene and set decontamination with 70% alcohol or an iodophor. 21, 27 In reality, staff techniques are divergent and may not be aseptic. 10 Failure to adhere to rigorous sterile technique on insertion and at every circuit manipulation would likely override any benefit of routinely replacing administration sets and may even encourage poor technique by relying on the procedure to intermittently "resterilize" the circuit.
The catheters used had a chlorhexidine gluconate and silver sulfadiazine external coating and have been shown to be effective at reducing rates of catheter colonization. 28 This may have outweighed any effect caused by administration set replacement. The overall incidences of colonization and catheter-related bacteremia were low. A meta-analysis of 12 studies involving identical catheters reported an average colonization rate of 16.2% (range, 0% to 39.7%) 28 compared with our mean of 7.7%. Administration set replacement may have an effect (positive or negative) on other catheter populations or in centers with higher baseline infection rates. However, it is difficult to imagine that benefits would approach those achieved by aseptic technique and stringent handwashing. The study included administration sets for parenteral nutrition, lipid, and propofol infusions, but not blood sets, which were discarded after use (< 24 hours). Fluid containers were routinely replaced after a maximum of 24 hours of use to isolate the effect of prolonged use of the administration set from that of the IV fluid container. It may be that fluid containers do not require routine replacement, but this issue was not addressed by the study.
The study was designed to detect a small 29 effect size of 0.14 on colonization at an alpha of 0.05 with 80% power. However, the incidences observed were lower than anticipated (group receiving no set change, 10%; group receiving a set change, 5%; effect size, 0.09). Routine set changes may entail a smaller level of risk than the study was designed to detect. Colonization was a surrogate endpoint for catheter-related bacteremia due to the statistical difficulties of using the infrequently diagnosed catheter-related bacteremia. Colonization may not be associated with deleterious symptoms, although it is to be avoided due to the potential for colonized catheters to progress to infection. 27, 30 Incidence of catheter-related bacteremia was the clinical phenomenon of interest and was identical (1.5% of catheters or 3 cases per 1,000 catheter-days) between the groups. This incidence was lower than that reported in the literature of 5 cases per 1,000 catheter-days. 21 There have been many previous studies into the optimal duration of IV administration set use. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 31, 32 These studies have been undertaken in a wide variety of patient, catheter, and infusion populations. Whereas studies have varied in definitions, endpoints, and size, none has found a significant difference in catheter colonization or catheterrelated or infusion-related bacteremia between groups with administration sets used for different times. One study of parenteral nutrition in neonates found a higher mortality rate and set fluid contamination in a group using sets for 72 hours compared with a group with a significantly higher birth weight using sets for 24 hours.
14 Previous studies predominantly examined periods of 72 hours or less and sought identification of an optimal time point for routine replacement of the administration set. Our study provides support for 7-day set use and questions whether routine changes are necessary at all with the use of a group of patients who were not subjected to the procedure at any time during catheterization.
Recent data on the testing of administration sets for 7 days of continuous use found them to remain accurate and in good physical condition. 33 Beyond this time, the durability of the materials is unknown. From an infection perspective, this study is the third to evaluate and support administration set use for 7 days. A randomized, controlled trial in a general ICU reported no difference in the colonization rates of 332 CVCs with sets replaced at 72 or 168 hours (1 week). 32 Another randomized, controlled trial enrolled 512 oncology patients with sets replaced within 3 days or between 4 and 7 days of placement. 19 Although only a small proportion of sets were used for 7 days, no effect on infusate-related bacteremia was found.
Routine administration set changes are costly to perform, at up to $200 (U.S.) per procedure for the equipment alone. Extension of set use to 7 days would result in significant cost savings, less environmental waste, and the redirection of nursing time to other patient care, education, or research activities. The complex procedure for a routine administration set change has a ritualistic status and may be difficult to reduce or disband, particularly among nurses who value "being busy" as a major theme of ICU care. 34 Staff should be reminded that there is an absence of supporting evidence for the procedure and a growing body of evidence suggesting its ineffectiveness. The evidence-based practice movement seeks to replace ritualistic and historically based care with treatment that is scientifically proven to be effective. The results of this study suggest that evidence-based practice will be achieved by extending IV administration set use to 7 days for short-term, antiseptic-coated CVCs.
